Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $65

Benzinga · 07/06 15:50
Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $78 to $65.